Immune thrombocytopenia (ITP) is an acquired immune-mediated disorder characterized by thrombocytopenia in the absence of an underlying cause. 1 The pathophysiology of ITP is multifactorial and includes the development of autoantibodies that trigger abnormal thrombopoiesis, enhanced platelet destruction, complement activation and T-cell-mediated effects. [1] [2] [3] Platelet autoantibodies are detected in about 50% of patients 4 and generally target the fibrinogen receptor α IIbβ3 or the receptor for von Willebrand factor (VWF), the glycoprotein (GP) Ib-V-IX complex.
Anti-αIIbβ3 antibodies (70-80% of cases) are thought to induce thrombocytopenia through increased platelet clearance by Fcγ receptor-bearing macrophages. Autoantibodies against GPIb-V-IX (20-40% of cases) often induce a more severe fall in platelet count 5 that is less responsive to standard therapies, such as intravenous immunoglobulin G (IVIG). 6 Thrombocytopenia induced by GPIb-V-IX autoantibodies has been characterized in little detail. Some monoclonal antibodies against GPIbα are known to induce platelet activation, 7 which may lead to accelerated platelet destruction in ITP patients 8 with autoantibodies against this receptor. Here we report how an autoantibody against GPIbα, obtained from a patient with ITP, induces recognition signals for macrophages through interplay between glycoprotein Ibα and the low affinity IgG receptor FcγRIIa in lipid rafts.
The patient is a 70 year old Caucasian woman. She had a history of nephrectomy and parathyroidectomy; both surgeries were without bleeding complications. In 2007, routine laboratory investigations revealed a thrombocytopenia (20x10 9 /L; normal 150-450x10 9 /L). Recently, she suffered from increased spontaneous skin hematomas and melena. Her platelet count was low (20x10 9 /L) and disturbed by aggregates. Hemoglobin level, leukocytes and differential were normal. There was no detectable monoclonal protein and immunoglobulin levels were normal. IVIG (30 g per day for 5 days) and platelet transfusions failed to increase platelet count to normal levels. Gastro-and colonoscopy did not reveal a clear bleeding focus (Supplementary Table S1 ). A detailed description of the materials and methods used is found in the Supplement.
Citrated blood from the ITP patient showed a mixture of single platelets and small aggregates.
Inhibition of platelet activation with prostacyclin (PGI 2 ) during blood collection reduced the number of aggregates, but the platelet count remained low ( Figure 1A ). FACS analysis with gating for single platelets showed increased levels of surface-expressed fibrinogen, P-selectin and PS compared with controls ( Figure 1B ). Surface-exposed P-selectin and PS are clearance signals, triggering platelet binding to macrophages, followed by their destruction. 9 As expected, matured monocytic THP-1 cells phagocytosed 21-fold more patient platelets than control platelets. The activation observed in blood was caused by a plasma constituent, since normal platelets incubated in patient plasma were also activated and showed a strong increase in surface-bound fibrinogen and P-selectin. IgG depletion prevented the increase in P-selectin expression, which was restored upon repletion of IgG ( Figure 1C ).
The observed platelet activation suggested the presence of anti-GPIbα autoantibodies, as some monoclonal anti-GPIbα antibodies are known to induce platelet aggregation. 7 Indeed, removal of GPIbα ectodomain with o-sialoglycoprotein endopeptidase (osge) or addition of excess soluble recombinant GPIbα reduced P-selectin expression on normal platelets incubated in patient plasma ( Figure 2A ). Binding of VWF to GPIbα triggers its translocation to cholesterol-rich domains known as lipid rafts. 10 Subsequent platelet activation by GPIbα involves signaling through immunoreceptor tyrosine-based activation motif-containing receptors, such as the Fc receptor γ chain (FcRγ) 11 or the low-affinity IgG receptor FcγRIIa. 12 To investigate whether a similar mechanism might function in autoantibody-induced platelet activation, suspensions of normal platelets in patient plasma were incubated with GM3 ganglioside, which inhibits GPIbα translocation to lipid rafts, 13 or with a neutralizing anti-FcγRIIa antibody (clone AT10). Both treatments strongly suppressed P-selectin expression induced by patient plasma (Figure 2A ). Antibody titer determination with immobilized recombinant GPIbα confirmed the presence of GPIbα autoantibodies in patient plasma ( Figure 2B ).
Direct analysis of IgG binding in suspensions of normal platelets in patient plasma confirmed the expected interference by recombinant GPIbα, whereas GM3 and anti-FcγRIIa antibody had no effect ( Figure 2C ). These data demonstrate that antibody binding is primarily regulated through GPIbα.
FRET measurement using FLIM is a sensitive technique to analyze protein colocalization on the intact platelet membrane. 13 Analysis of normal platelets revealed that little GPIbα was present in lipid rafts ( Figure 2D ). The receptor was dispersed over the surface and formed little associations with FcγRIIa.
Incubation in patient plasma induced GPIbα translocation to rafts, the formation of GPIbα clusters and GPIbα association with FcγRIIa. Addition of GM3 not only induced the expected blockade of GPIbα translocation to rafts but also prevented formation of GPIbα clusters and GPIbα association with FcγRIIa. Collectively, these findings indicate that patient autoantibodies against GPIbα trigger surface expression of GPIbα clusters, P-selectin and PS, which are all 'eat-me' signals for macrophages.
9;14
Crucial is the association with lipid rafts, both for formation of GPIbα clusters and activation of FcγRIIa, whose ligand-binding properties are enhanced by localization to rafts. 15 The result is a more severe drop in platelet count compared to patients with anti-αIIbβ3 antibodies. 5 The fact that have dispersed GPIbα receptors that do not co-localize with GM1, a marker for lipid rafts, or FcγRIIa.
Platelet incubation in patient plasma triggers GPIbα translocation to rafts, leading to its clustering and association with FcγRIIa, which is prevented by addition of GM3. Data are means ± SEM (n=3). 
Supplementary Methods

Materials and antibodies
We used the following products (with sources 
Blood collection, platelet isolation and incubations
Procedures were approved by the Medical Ethical Committee of our hospital. Platelets from healthy, medication-free volunteers were isolated 4 and resuspended in Hepes-Tyrode (HT) buffer (pH 7.3).
Whole blood and isolated platelets were analyzed using the Cell-Dyn Sapphire hematology analyzer (Abbott Diagnostics, Santa Clara, CA, USA). The patient platelets aggregated spontaneously during blood collection in vacuum tubes containing citrate, coated EDTA-K2 or sodium-heparin, preventing investigations. To reduce aggregation to a minimum, patient blood was collected by free-flow; the first 2 ml was discarded and the remainder collected in 13 mM citrate (f.c.), supplemented with 10 ng/mL PGI 2 to induce transient platelet inhibition. Patient platelets were subsequently isolated as described. 
Flow cytometric analysis
Characterization of platelets by Fluorescence-Activated Cell Sorting (FACS) was based on forwardand side-scatter (FSC/SSC) (FACS-Calibur; BD Biosciences, San Jose, CA). Platelets were incubated with appropriate antibodies (15 minutes, 37 °C) and 10,000 platelets were analyzed for surface expression of P-selectin, phosphatidylserine (PS), fibrinogen and binding of human IgGs. Results were expressed as ratio of patient data/control data.
Plasma depletion from IgGs
Patient plasma and plasma pooled from 200 healthy donors was depleted from IgG by passage through a Protein G-sepharose column. The effluent was collected and stored at -80 ºC before experiments.
Bound IgG was eluted and dialyzed thrice against a large excess of 10 mM Hepes, 154 mM NaCl, pH 7.4 for 6 hours. IgG was stored at -80⁰C until used for repletion studies.
Antibody titer determination by ELISA
Antibody titer of GPIbα antibodies was determined by ELISA. Wells were coated with 10 μg/mL of fully sulphated recombinant GPIbα (residues 1-298), 1 
Analysis of GPIbα distribution by Förster Resonance Energy Transfer using Fluorescence Lifetime Imaging Microscopy (FRET/FLIM)
GPIbα distribution by FRET/FLIM was analyzed as described before. 3 
Statistical analysis
Data are means ± SEM with number of experiments (n), as indicated. Statistical analysis was performed using GraphPad Prism 5 (San Diego, CA) software. Differences between control platelets and incubations were analyzed by Mann-Whitney test. P-values <0.05 (*) were considered significant.
Supplementary Table S1: Hematology parameters
Coagulation assays were performed on a Sta-rack coagulation analyzer (Diagnostics Stago, Asnieres, France).
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